PIGL, phosphatidylinositol glycan anchor biosynthesis class L, 9487
N. diseases: 152; N. variants: 11
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | Neoplastic Process | 1293 | 222 | 0.010 | None | 1.000 | 1 | 1997 | 1997 | |||||
|
disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Nervous System Diseases | Disease or Syndrome | 28 | 0.010 | None | 1.000 | 1 | 1997 | 1997 | ||||||
|
disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | Neoplastic Process | 879 | 168 | 0.010 | None | 1.000 | 1 | 1997 | 1997 | |||||
|
group | Mental Disorders | Mental or Behavioral Dysfunction | 789 | 149 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | |||||
|
disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | Congenital Abnormality | 129 | 21 | 0.010 | None | 1.000 | 1 | 2008 | 2008 | |||||
|
disease | Nutritional and Metabolic Diseases; Nervous System Diseases | Disease or Syndrome | 1114 | 485 | 0.100 | None | 1.000 | 2 | 1 | 2013 | 2014 | ||||
|
phenotype | Laboratory Procedure | 681 | 1322 | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | |||||
|
phenotype | Clinical Attribute | 430 | 746 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 145 | 234 | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 100 | 150 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 272 | 452 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Mental Process | 854 | 2127 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
phenotype | Clinical Attribute | 507 | 1037 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||
|
phenotype | Laboratory Procedure | 610 | 1144 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Finding | 112 | 9 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 37 | 3 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 46 | 7 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 79 | 8 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 34 | 5 | 0.100 | None | 0 | |||||||||
|
disease | Anatomical Abnormality | 95 | 8 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 145 | 10 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 117 | 1 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 110 | 13 | 0.100 | None | 0 | |||||||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications | Finding | 43 | 10 | 0.100 | None | 0 | ||||||||
|
phenotype | Congenital Abnormality | 45 | 7 | 0.100 | None | 0 |